GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AR, AXL, BCL2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, GPER1, HSD17B2, HTR5A, IGF1R, MMP2, MMP9, POLB, RORC, SRC, TYR |
9.36848 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, ALOX15, ALPL, APEX1, AR, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, HTR5A, IGF1R, KDR, MMP2, POLB, RORC, SRC, TYR |
9.09555 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, AKR1B1, ALOX15, ALPL, APEX1, AR, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MMP2, MMP9, POLB, RORC, SRC, TYR |
9.0073 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, AR, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FLT3, GPER1, HTR5A, RORC, SRC, TYR |
8.8213 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, APEX1, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, F10, F3, FABP3, FABP4, FLT3, GPER1, HCAR2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, KDR, MET, POLA1, POLB, SRC, XDH |
8.32391 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
8.31052 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AR, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, GPER1, HCAR2, HTR2A, HTR2B, HTR6, KDR, MET, MMP9, SRC, XDH |
8.11625 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AR, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, GPER1, HCAR2, HTR2A, HTR2B, HTR6, KDR, MET, MMP9, SRC, XDH |
8.09963 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, DRD3, GPER1, HTR2A, HTR2B, KDR, SRC |
7.88072 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA6, CA7, CA9 |
7.33869 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD17B2, HTR5A, RORC, SRC, TYR |
7.25215 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALDH2, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FDPS, FUT7, GLO1, HTR2B, PIM1, TBXAS1, TYR, XDH |
7.08764 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AR, AXL, BCL2, CYP1B1, DRD2, F10, F3, FLT3, GPER1, HTR2A, HTR2B, HTR6, KDR, MET, SRC, XDH |
6.90211 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, FLT3, GPER1, HTR2A, HTR2B, MET, POLA1, POLB, SRC |
6.81607 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, AR, BCL2, CYP1B1, DRD2, DRD3, ESR1, ESRRA, F3, FABP3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, PIM1, SRC, XDH |
6.81607 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.81607 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.81607 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, BCL2, CYP1B1, ESR1, F3, FLT3, GLO1, GPER1, HCAR2, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, SIGMAR1, SRC, TOP2A, XDH |
6.76286 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, APEX1, AR, AURKB, AXL, BCL2, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, RORC, SRC, TOP2A, XDH |
6.67452 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
6.48562 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, APEX1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, KDR, POLB, SRC |
6.4043 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SRC |
6.33949 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, AKR1B1, ALOX15, ALOX5, ALPL, AR, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRB, F10, F3, FABP4, GPER1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, MET, MMP1, MMP2, MMP9, PIM1, RORC, SRC, TYR |
6.33949 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, ALPL, APEX1, AR, AURKB, AXL, BCL2, CA2, CA6, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, GPER1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MMP2, MMP9, POLA1, POLB, RORC, SRC, TOP2A, TYR |
6.33949 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, DRD3, GPER1, HTR1A, HTR5A, HTR6, HTR7 |
6.29101 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, ALPL, APEX1, AR, BCL2, CA2, CA9, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, GPER1, HTR5A, IGF1R, MMP2, SRC |
6.24355 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, ALPL, APEX1, AR, BCL2, CA2, CA9, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, HTR5A, SRC |
6.24355 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, BCL2, CYP1B1, ESR1, F3, FLT3, GLO1, GPER1, HCAR2, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, SIGMAR1, SRC, TOP2A, XDH |
6.24355 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, DRD1, DRD2, DRD3, GPER1, HCAR2, HTR2A, HTR2B, KDR, SRC |
6.24195 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, BCL2, CYP1B1, ESR1, F3, FLT3, GLO1, GPER1, HCAR2, HTR2B, IGF1R, KDR, MMP9, PIM1, SIGMAR1, SRC, TOP2A, XDH |
6.21985 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, POLB, SRC |
6.15383 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, ALPL, APEX1, AR, AURKB, AXL, BCL2, CA2, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, HSD17B2, HTR2A, HTR2B, HTR5A, KDR, MET, MMP2, MMP9, PIM1, POLB, RORC, SIGMAR1, SRC, TOP2A, TYR |
6.1514 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AR, AURKB, AXL, BCL2, CYP1B1, DRD2, DRD3, ESR1, F10, F3, FLT3, GPER1, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, SRC, XDH |
6.1514 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALDH2, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, FDPS, HTR1A, TYR |
6.02204 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, DRD1, GPER1, HTR1A, HTR2A, HTR2B, HTR7, SRC |
5.79126 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, DRD3, GPER1, HTR1A, HTR5A, HTR7 |
5.77353 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.74896 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, APEX1, AR, AURKB, AXL, BCL2, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, RORC, SRC, TOP2A, XDH |
5.71572 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, DRD3, FABP3, FDPS, FLT3, GPER1, HCAR2, HTR2A, HTR2B, RORC, SRC |
5.68376 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AR, AXL, BCL2, CYP1B1, DRD2, DRD3, F10, F3, FLT3, GPER1, HTR2A, HTR2B, HTR6, KDR, MET, MMP9, SRC, XDH |
5.53232 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AR, AURKB, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F10, F3, FLT3, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, SRC, XDH |
5.49852 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, BCL2, DRD2, DRD3, ESR1, F3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, PIM1 |
5.43186 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, SRC |
5.43186 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, DRD3, HTR1A, TYR |
5.41729 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, SRC |
5.41123 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PIM1, RORC, SRC |
5.41123 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AR, AURKB, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F10, F3, FLT3, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, SRC, XDH |
5.39983 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, DRD1, GPER1, HTR1A, HTR2A, HTR2B, HTR7 |
5.3682 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, DRD1, GPER1, HTR1A, HTR2A, HTR2B, HTR7 |
5.3682 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
5.27368 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, RORC, SRC |
5.22296 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, ALDH2, ALOX15, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, RORC, SRC, TBXAS1, TOP2A, TYR, XDH |
5.18159 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, DRD1, GPER1, HTR1A, HTR2A, HTR2B, HTR7 |
5.18139 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, DRD1, GPER1, HTR1A, HTR2A, HTR2B, HTR7 |
5.16084 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, SRC |
5.1165 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, GPER1, HCAR2, HSD17B2, HTR1A, HTR2A |
5.1165 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, ESR1, FABP3, FABP4, FDPS, FUT7, HSD17B2, MET, TBXAS1 |
5.06504 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, APEX1, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, MMP2, MMP9, RORC, SRC |
5.06463 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, APEX1, AR, AXL, BCL2, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, MMP2, RORC, SRC |
5.01829 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1 |
5.01829 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALDH2, ALOX15, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP2, PIM1, POLA1, POLB, RORC, SRC, TBXAS1, TOP2A, TYR, XDH |
5.00857 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, AR, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, GPER1, RORC, SRC |
4.93947 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, DRD1, GPER1, HTR1A, HTR2A, HTR2B, HTR7, SRC |
4.92693 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1 |
4.88394 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
4.88394 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, F10, F3, GPER1, MET, SRC, XDH |
4.83249 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AR, AXL, BCL2, CYP1B1, DRD2, DRD3, ESRRA, F10, F3, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR6, KDR, MET, MMP2, MMP9, SRC, XDH |
4.81882 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, AR, BCL2, CYP19A1, ESR1 |
4.81882 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, SRC |
4.70344 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1 |
4.69622 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2 |
4.68355 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
4.63067 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, GPER1, HTR2A |
4.60183 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, GPER1, HTR2A |
4.60183 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AR, AXL, BCL2, CA2, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, POLB, SRC, TYR |
4.51464 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, RORC, SRC |
4.51271 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, APEX1, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, MMP2, MMP9, POLA1, POLB, RORC, SRC, TOP2A |
4.46355 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.46355 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.46355 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX15, APEX1, AR, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, SRC |
4.46355 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, GPER1, HTR2A, HTR2B, MET |
4.42724 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, ALPL, AR, AXL, BCL2, CA2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, HTR5A, KDR, MMP9, PIM1, POLB, RORC, SIGMAR1, SRC, TYR |
4.40024 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FDPS, HSD17B2 |
4.32159 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, ALOX15, AR, DRD2, FLT3, GPER1, HTR2A, HTR2B, KDR, SRC, XDH |
4.30584 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, GPER1 |
4.30584 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, BCL2, DRD1, DRD2, ESRRB, FABP3, FLT3, GPER1, HTR2A, HTR2B, KDR, MMP9, SRC, XDH |
4.28739 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, BCL2, DRD1, DRD2, ESRRB, FABP3, FLT3, GPER1, HTR2A, HTR2B, KDR, MMP9, SRC, XDH |
4.28739 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, DRD2, DRD3, FABP3 |
4.28739 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
4.24588 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
4.10948 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, CA2, DRD1, DRD2, DRD3, ESR1, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1, SRC |
4.06167 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CYP1A1, ESR1, FLT3, HTR1A, MET, PIM1, POLA1, SRC, TYR |
4.04249 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, ALOX15, DRD2, GPER1, HTR2A, HTR2B, KDR, SRC |
4.04249 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, AKR1B1, AR, AXL, BCL2, CA1, CA2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, MMP9, PIM1, POLB, RORC, SIGMAR1, SRC |
4.03093 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALDH2, ALOX15, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD17B2, TBXAS1, TYR, XDH |
4.02178 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP3, GPER1, HTR2A, HTR2B |
3.94776 |
[BP] GO:0007200 |
None
|
ADRA1A, DRD1, DRD2, ESR1, HTR2A, HTR2B |
3.94598 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
3.94598 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, DRD2, DRD3, ESR1, HTR7, RORC, SRC, TOP2A |
3.89026 |
[BP] GO:0019933 |
None
|
ADRA1A, DRD1, DRD2, DRD3, GPER1, HTR5A |
3.8447 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, AR, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, ESRRB, F3, GPER1, HCAR2, HTR2A, HTR2B, KDR, MET, MMP9, PIM1, SRC |
3.66855 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1 |
3.66855 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, GPER1, HCAR2 |
3.64229 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, ALOX15, AR, DRD2, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, SRC, XDH |
3.64146 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APEX1, AR, AURKB, AXL, BCL2, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPER1, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, RORC, SRC, TOP2A, XDH |
3.6295 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1 |
3.6295 |
[BP] GO:0019935 |
None
|
ADRA1A, DRD1, DRD2, DRD3, GPER1, HTR5A |
3.6295 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, APEX1, AR, AURKB, AXL, BCL2, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPER1, HCAR2, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, RORC, SRC, TOP2A, XDH |
3.5703 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, ALOX15, AR, BCL2, DRD2, ESRRB, FLT3, GPER1, HTR2A, HTR2B, KDR, MMP9, SRC, XDH |
3.53779 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, DRD1, DRD2, DRD3, GPER1, HTR2B, HTR5A, KDR |
3.53551 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, BCL2, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MMP9, SRC, XDH |
3.51525 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, BCL2, DRD2, DRD3, ESR1, GPER1, IGF1R, MET, MMP9, SRC, XDH |
3.49085 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, GLO1, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, SRC |
3.49077 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AR, BCL2, DRD1, DRD2, DRD3, ESR1, ESR2, GPER1, HTR2A, IGF1R, MET, MMP9, SRC, XDH |
3.48299 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, DRD3, HTR2A, HTR2B, MMP2, POLB, SRC, TYR |
3.4791 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, BCL2, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MMP9, SRC, XDH |
3.47822 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.47822 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.47822 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, AR, BCL2, DRD1, DRD2, DRD3, ESR1, ESR2, GPER1, HTR2A, IGF1R, MET, MMP9, SRC, XDH |
3.47797 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.47675 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
3.47675 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.47675 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AR, AXL, CYP1B1, DRD1, ESR1, GPER1, IGF1R, MMP2, MMP9, RORC, SRC |
3.46132 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, ALDH2, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3 |
3.43701 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
3.41987 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC |
3.40386 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, AURKB, BCL2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, RORC, SRC, TOP2A, XDH |
3.38304 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A |
3.36699 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.3362 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, DRD2, DRD3, FABP3 |
3.32251 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, DRD1, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, SRC |
3.30068 |
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, APEX1, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B, POLA1 |
3.28289 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET |
3.28268 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.25974 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
3.24974 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, ALOX15, AR, BCL2, DRD1, DRD2, ESRRB, FABP4, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MMP9, SRC, XDH |
3.24619 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.20152 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, AURKB, BCL2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, RORC, SRC, TOP2A, XDH |
3.18341 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, DRD1, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, SRC |
3.18341 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
3.18252 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
3.16469 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
3.15065 |
[BP] GO:0007189 |
None
|
ADRA1A, DRD1, DRD2, DRD3, GPER1 |
3.15065 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, ALOX15, AR, BCL2, DRD2, FLT3, GPER1, HTR2A, HTR2B, KDR, MMP9, SRC, XDH |
3.14596 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, ALOX15, AR, BCL2, DRD1, DRD2, FABP4, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MMP9, SRC, XDH |
3.14596 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, ALOX15, DRD2, GPER1, HTR2A, HTR2B, KDR, SRC |
3.1394 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, GLO1, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, SRC |
3.12451 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, ALOX15, DRD1, GPER1, HTR1A, HTR2A, HTR2B, HTR7 |
3.10684 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
3.10684 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, DRD1, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, SRC |
3.10582 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.10233 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.10233 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, HTR6 |
3.09049 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, FABP3, FABP4, FDPS, FUT7, MET, TBXAS1 |
3.07476 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3, HTR2A |
3.06311 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
3.04687 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
3.0139 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1, SRC |
3.0139 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, GPER1, HCAR2, HTR2B, SRC |
3.00891 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, DRD1, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, SRC |
2.99495 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, GLO1, HTR2B, IGF1R, KDR, MMP9, PIM1, SRC |
2.96264 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, DRD3, GPER1, HTR1A, HTR2A, MMP9 |
2.94611 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, TBXAS1 |
2.93728 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AR, AURKB, AXL, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP2, MMP9, SRC, XDH |
2.92671 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
2.92671 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, DRD2, DRD3, HTR2A, MMP9 |
2.91811 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.90456 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
2.90456 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.90209 |
[BP] GO:0006286 |
base-excision repair, base-free sugar-phosphate removal
|
APEX1, POLB |
2.90209 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
2.89866 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HTR2A, HTR2B, SRC |
2.88155 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, FLT3, GPER1, SRC |
2.86812 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
2.84639 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AR, AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MET, RORC, SRC, TOP2A |
2.82752 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, AR, AURKB, AXL, BCL2, DRD2, DRD3, ESR1, GPER1, IGF1R, KDR, MET, MMP1, MMP9, SRC |
2.82752 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.82752 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.82752 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.82752 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, AURKB, BCL2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, RORC, SRC, TOP2A, XDH |
2.81142 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, DRD1, DRD2, DRD3, FABP3, FLT3, GPER1, IGF1R, MMP2, SRC, TYR |
2.81035 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, ALOX15, AR, BCL2, CYP19A1, DRD1, DRD2, DRD3, ESR1, ESR2, GPER1, IGF1R, MET, MMP9, SRC, XDH |
2.80871 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.80002 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.80002 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, HTR2A, MET |
2.79733 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, AURKB, BCL2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, RORC, SRC, TOP2A, XDH |
2.79473 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, DRD3, GPER1, HTR1A |
2.77729 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
2.76712 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AR, AURKB, AXL, BCL2, CYP1B1, DRD2, DRD3, ESR1, ESR2, F10, F3, FLT3, GPER1, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, SRC, XDH |
2.76712 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9 |
2.76289 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.75503 |
[BP] GO:0007568 |
aging
|
ADRA1A, APEX1, AURKB, BCL2, CYP1A1, HTR2A, POLB |
2.75484 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
2.72573 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, APEX1, AR, AURKB, BCL2, CA9, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, GLO1, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, POLA1, RORC, SRC, TOP2A, XDH |
2.69695 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, AKR1B1, AXL, BCL2, CYP1B1, DRD1, DRD2, DRD3, GPER1, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MET, POLB, SRC |
2.681 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.67802 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.67802 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.67802 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, RORC |
2.67599 |
[BP] GO:0003014 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, DRD2 |
2.66556 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, ALDH2, AOX1, CYP19A1, CYP1A2, XDH |
2.64894 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, RORC, TOP2A |
2.62561 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.60702 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, GPER1, HTR2A, HTR2B |
2.57766 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, SRC |
2.57309 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, ALDH2, ALOX15, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, RORC, SRC, TBXAS1, TOP2A, TYR, XDH |
2.56407 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.53178 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, DRD1, DRD2, DRD3, FABP3, FLT3, GPER1, IGF1R, MMP2, SRC, TYR |
2.52973 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, DRD3, GPER1, HCAR2, HTR2B, SRC |
2.51215 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, GPER1, HTR1A |
2.51215 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, GPER1, HCAR2, HTR2B, SRC |
2.51215 |
[BP] GO:0098502 |
DNA dephosphorylation
|
APEX1, POLB |
2.50997 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.50997 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.50997 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.50997 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALDH2, ALOX15, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, GPER1, HCAR2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, RORC, SIGMAR1, SRC, TBXAS1, TOP2A, TYR, XDH |
2.48854 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.47594 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.47594 |
[BP] GO:0006721 |
terpenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, FDPS |
2.46943 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, MMP9, RORC |
2.46235 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CYP19A1, DRD2, GPER1, HCAR2, HTR1A, HTR2A |
2.44291 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2 |
2.441 |
[BP] GO:0051898 |
None
|
DRD2, DRD3, GPER1, XDH |
2.441 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.441 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AR, AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, HTR2A, HTR2B, IGF1R, MET, RORC, SRC, TOP2A |
2.44077 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.44019 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.43133 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, DRD1, DRD2, FDPS, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, POLB, SRC, XDH |
2.42798 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.42798 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, DRD1, DRD2, DRD3, HTR1A |
2.41631 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA1A, ALOX15, APEX1, AR, AURKB, BCL2, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, GLO1, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, POLA1, RORC, SRC, TOP2A, XDH |
2.41299 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, AR, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, ESR1, ESRRA, ESRRB, F3, GPER1, HCAR2, HTR2A, HTR2B, KDR, MET, MMP9, PIM1, SRC, XDH |
2.41079 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, SRC |
2.39357 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B |
2.39195 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, GLO1, TBXAS1 |
2.38711 |
[BP] GO:0051282 |
None
|
DRD1, DRD2, GPER1, HTR2A, HTR2B |
2.38711 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, ALDH2, ALOX15, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B2, HTR2B, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, RORC, SRC, TBXAS1, TOP2A, TYR, XDH |
2.38711 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.37833 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.37833 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.37833 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.37673 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, RORC |
2.37673 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
2.35732 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.35732 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, HTR2A |
2.35732 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP2D6 |
2.35732 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, AR, AXL, BCL2, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7 |
2.35532 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, SRC |
2.35451 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.35271 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.32998 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.31999 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, ALDH2, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FABP4, FUT7, MMP1, MMP2, MMP9, SRC, XDH |
2.31467 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.31006 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, BCL2, CA2, CA9, ESR1, MET, SRC |
2.30613 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, DRD1, KDR, SRC |
2.30613 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.29962 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.29166 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.28914 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.28834 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.28834 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, GPER1, HTR2A, HTR2B |
2.28834 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, FLT3, IGF1R, KDR, PIM1, SRC |
2.28834 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.28834 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.28834 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, AXL, BCL2, CA2, CA7, CYP19A1, DRD1, DRD2, DRD3, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, MMP9, SRC |
2.26176 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, AR, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7 |
2.2607 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
2.25687 |
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.25103 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AR, AXL, BCL2, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD17B2, MMP2, MMP9, SRC, TOP2A |
2.24842 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, ESR1, ESRRA, GPER1, HTR5A |
2.24842 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, POLB, SRC |
2.24842 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B2 |
2.24842 |
[BP] GO:0007202 |
None
|
ADRA1A, HTR2A, HTR2B |
2.24842 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.24842 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, FDPS |
2.2341 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, DRD1, DRD2, FDPS, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, POLB, SRC, XDH |
2.23007 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, BCL2, DRD2, ESR1, F3, FLT3, GPER1, HTR2A, HTR2B, KDR, MMP9, SRC, XDH |
2.21865 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, ALOX15, AR, BCL2, DRD2, FLT3, GPER1, HTR2A, HTR2B, KDR, MMP9, SRC, XDH |
2.21356 |
[BP] GO:0051271 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.20898 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, RORC |
2.20185 |
[BP] GO:0045913 |
None
|
ESRRB, GPER1, HTR2A, SRC |
2.16596 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, CYP1B1, DRD1, DRD2, DRD3, GPER1, HTR1A, HTR2A, HTR2B, HTR7, SRC, TYR |
2.15535 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3 |
2.15461 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, GPER1, KDR, MET |
2.15167 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.11047 |
[BP] GO:0045745 |
None
|
DRD2, DRD3, GPER1 |
2.11047 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, AR, AURKB, BCL2, DRD2, ESR1, ESR2, F3, FLT3, GPER1, HTR2A, HTR2B, MET, MMP9, SRC, XDH |
2.11047 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.11047 |
[BP] GO:0098501 |
polynucleotide dephosphorylation
|
APEX1, POLB |
2.11047 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.11047 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.11047 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.11047 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.11047 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.11047 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.11047 |
[BP] GO:0030263 |
None
|
GPER1, TOP2A |
2.11047 |
[BP] GO:0040013 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.10913 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AR, AURKB, AXL, BCL2, CYP1A1, CYP1A2, CYP2D6, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GLO1, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, POLB, SRC, TOP2A, TYR, XDH |
2.09732 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, AR, AURKB, BCL2, DRD1, DRD2, DRD3, ESR1, F3, FABP4, FLT3, GPER1, HTR2A, HTR2B, IGF1R, MMP9, SRC, XDH |
2.09732 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, AR, AXL, BCL2, CYP1A1, DRD1, DRD2, ESR1, ESRRB, FABP4, FLT3, FUT7, GLO1, HTR2B, KDR, MET, MMP2, MMP9, RORC, SRC, TOP2A |
2.09339 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.08201 |
[BP] GO:0014059 |
None
|
DRD2, DRD3, HTR2A |
2.08201 |
[BP] GO:0055065 |
metal ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
2.05756 |
[BP] GO:0071383 |
None
|
AR, FLT3, GPER1, SRC |
2.05567 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA1A, ALOX15, AR, BCL2, DRD1, DRD2, FABP4, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MMP9, SRC, XDH |
2.04889 |
[BP] GO:0060401 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.01308 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, AR, DRD1, ESR1, FLT3, GPER1, IGF1R, MMP2, SRC |
2.00795 |
[BP] GO:0051302 |
None
|
AURKB, DRD2, DRD3, ESRRB, HTR2B |
2.00561 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A |
2.00273 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A |
2.00273 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, AXL, CA4, DRD1, DRD2, DRD3, F10, F3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
5.75702 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
4.17559 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, ALPL, AR, AXL, CA12, CA14, CA2, CA4, CA9, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, GLO1, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIM1, SRC |
3.88143 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, ALOX15, AXL, CA2, CA4, CA9, DRD1, DRD2, DRD3, F10, F3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SRC |
3.8447 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GPER1, HCAR2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MPEG1, SIGMAR1, SRC, TBXAS1, TYR |
3.16469 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, ALOX5, ALPL, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GLO1, GPER1, HCAR2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIM1, SIGMAR1, SRC, TBXAS1, TYR |
3.11804 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.42798 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALDH2, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CA1, CA2, CA4, CA6, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, GPER1, HTR2A, HTR5A, IGF1R, KDR, MMP2, MMP9, PIM1, POLA1, POLB, RORC, SHBG, SIGMAR1, SRC, TOP2A, TYR, XDH |
2.20013 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, AXL, CA12, CA14, CA4, CA9, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GPER1, HCAR2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MPEG1, SIGMAR1, TBXAS1, TYR |
2.13442 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, BCL2, CA4, CYP19A1, CYP2D6, FLT3, GPER1, HTR5A, KDR, SIGMAR1, XDH |
2.09732 |
[CC] GO:0031253 |
None
|
ADORA1, CA4, CA9, DRD1, DRD2, GPER1, SRC |
2.07453 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALDH2, ALOX15, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CA1, CA2, CA4, CA6, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, GPER1, HTR2A, HTR5A, HTR6, IGF1R, KDR, MMP2, MMP9, PIM1, POLA1, POLB, RORC, SHBG, SIGMAR1, SRC, TOP2A, TYR, XDH |
2.07159 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, AR, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP2, MMP9, PIM1, RORC, TBXAS1, TYR, XDH |
13.5941 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FDPS, FLT3, GLO1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, RORC, SRC, TBXAS1, TOP2A, TYR, XDH |
12.0455 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
12.0455 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, FDPS, GLO1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, RORC, TBXAS1, TOP2A, TYR, XDH |
11.5503 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AR, AXL, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, RORC, SIGMAR1 |
9.47628 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, POLB |
9.36848 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, AR, AXL, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, RORC, SIGMAR1 |
8.55874 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, AR, AXL, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, RORC, SIGMAR1 |
8.31052 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
8.12973 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, AR, AXL, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, RORC, SIGMAR1 |
7.80012 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
7.64214 |
[MF] GO:0008227 |
None
|
ADRA1A, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.53319 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, GLO1, POLB |
7.26304 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.81607 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.81607 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.81607 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.81607 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.81607 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1, XDH |
6.75801 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, RORC |
6.60203 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, RORC |
6.60203 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, RORC, SHBG |
6.37381 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F10, FDPS, GLO1, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, RORC, TBXAS1, TOP2A, TYR, XDH |
6.20385 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, F3, FLT3, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
6.16163 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, F3, FLT3, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
6.16163 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, RORC |
6.16163 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP2, MMP9, RORC |
5.92258 |
[MF] GO:0099528 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
5.79312 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALDH2, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, F10, F3, FDPS, FLT3, FUT7, GLO1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, SRC, TBXAS1, TOP2A, TYR, XDH |
5.49852 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.3274 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
5.09477 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.08623 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALDH2, ALOX15, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD17B2, TBXAS1, TYR, XDH |
5.01829 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1, TYR |
4.93449 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, GPER1, RORC, SHBG |
4.63067 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, SRC, TBXAS1 |
4.16031 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, DRD1, DRD2, DRD3, GPER1, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
4.14768 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PIM1, SIGMAR1, SRC, TOP2A |
4.11948 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
4.11948 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
4.02464 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, SRC, TBXAS1 |
3.97478 |
[MF] GO:0048037 |
cofactor binding
|
ALDH2, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, POLA1, SRC, TBXAS1, XDH |
3.74013 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1, TYR |
3.66855 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, ALDH2, AOX1, CYP19A1, CYP1A2, XDH |
3.47675 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.42586 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
2.99531 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.99495 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.90456 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.90209 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ALDH2, AOX1, APEX1, AR, AURKB, AXL, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FDPS, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, PIM1, POLA1, POLB, RORC, SHBG, SRC, TBXAS1, TOP2A, XDH |
2.8796 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, GPER1, IGF1R, SHBG |
2.87072 |
[MF] GO:0016903 |
None
|
AKR1B1, ALDH2, AOX1, XDH |
2.76712 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.42798 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3 |
2.42798 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.28834 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.28834 |